Local Institution - 0116

Fuzhou, Fujian 350028

1 studies enrolling now · 1 studies all time

What they study most

Hepatocellular Carcinoma (HCC)

Studies at this site

• A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206) — Recruiting now